About BioMarker Strategies
BioMarker Strategies is a company based in Rockville (United States) founded in 2007.. BioMarker Strategies has raised $7.25 million across 14 funding rounds from investors including HHS, National Cancer Institute and NIH SBIR/STTR. BioMarker Strategies offers products and services including SnapPath Cancer Diagnostics System and PathMAP Functional Signaling Profiles. BioMarker Strategies operates in a competitive market with competitors including Guardant Health, Natera, Denali Therapeutics, Foundation Medicine and ArcherDX, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.25 M (USD)
in 14 rounds
-
Latest Funding Round
$299.34 K (USD), Grant
Sep 22, 2017
-
Investors
HHS
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioMarker Strategies
BioMarker Strategies offers a comprehensive portfolio of products and services, including SnapPath Cancer Diagnostics System and PathMAP Functional Signaling Profiles. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automates profiling of live tumor cells for predictive cancer treatment selection.
Generates predictive profiles from live cells for targeted therapy responses.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of BioMarker Strategies
BioMarker Strategies has successfully raised a total of $7.25M across 14 strategic funding rounds. The most recent funding activity was a Grant round of $299.34 thousand completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Grant — $299,340
-
First Round
First Round
(23 Jun 2008)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2017 | Amount | Grant - BioMarker Strategies | Valuation |
investors |
|
| Aug, 2016 | Amount | Series A - BioMarker Strategies | Valuation |
investors |
|
| Jul, 2016 | Amount | Grant - BioMarker Strategies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioMarker Strategies
BioMarker Strategies has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, National Cancer Institute and NIH SBIR/STTR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Cancer research is conducted and supported by the institute.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioMarker Strategies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioMarker Strategies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomarker Strategies Comparisons
Competitors of BioMarker Strategies
BioMarker Strategies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Denali Therapeutics, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biomarker Strategies
Frequently Asked Questions about BioMarker Strategies
When was BioMarker Strategies founded?
BioMarker Strategies was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is BioMarker Strategies located?
BioMarker Strategies is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Is BioMarker Strategies a funded company?
BioMarker Strategies is a funded company, having raised a total of $7.25M across 14 funding rounds to date. The company's 1st funding round was a Grant of $2.3M, raised on Jun 23, 2008.
What does BioMarker Strategies do?
BioMarker Strategies was founded in 2007 in Rockville, United States, within the biotechnology sector focused on oncology. Cancer diagnostics systems, including SnapPath, are developed to enable predictive tests that guide targeted drug development and treatment selection for patients with solid tumor malignancies. PathMAP functional signaling profiles are generated using this system, serving as biomarker tests to predict individual responses to targeted therapies.
Who are the top competitors of BioMarker Strategies?
BioMarker Strategies's top competitors include Guardant Health, Juno Therapeutics and Foundation Medicine.
What products or services does BioMarker Strategies offer?
BioMarker Strategies offers SnapPath Cancer Diagnostics System and PathMAP Functional Signaling Profiles.
Who are BioMarker Strategies's investors?
BioMarker Strategies has 4 investors. Key investors include HHS, National Cancer Institute, NIH SBIR/STTR, and Abell Foundation.